Phoenix International Holdings

Final Days to Register for the 2 Day Online Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World Training Course (March 7-8, 2024)

Retrieved on: 
Monday, February 12, 2024

What are the core competencies of effective leaders in the pharmaceutical industry?

Key Points: 
  • What are the core competencies of effective leaders in the pharmaceutical industry?
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal 2017.

Agile Leadership for Pharma and Biopharma Professionals in a Hybrid World Training Course (Online Event) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, February 6, 2024

What are the core competencies of effective leaders in the pharmaceutical industry?

Key Points: 
  • What are the core competencies of effective leaders in the pharmaceutical industry?
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal 2017.

Federal Award to Help Make North Dakota the “Epicenter of AgTech” Supporting Innovation, Jobs, and Economic Growth

Retrieved on: 
Monday, January 29, 2024

The competitive award will fund programs that help solve food insecurity and expand economic opportunities for not only more people and organizations, but for increasing the growth of existing crops and introducing new crops to market.

Key Points: 
  • The competitive award will fund programs that help solve food insecurity and expand economic opportunities for not only more people and organizations, but for increasing the growth of existing crops and introducing new crops to market.
  • The award highlights the state’s talent pool in AgTech and recognizes the unique collaborative partnership that came together to show how North Dakota feeds the world.
  • Encourage involvement and investment from the private sector, non-profit organizations, and the broader North Dakota agricultural community.
  • The NSF Engines: North Dakota Advanced Agriculture Technology Engine is supported by the U.S. National Science Foundation under Award #2315315.

2023 CAPA (Corrective and Preventative Action) Procedures Training Course: How to Improve your Processes and Implement and Document an Effective CAPA Quality System

Retrieved on: 
Friday, October 27, 2023

Implementation - execute the action plan, eg stakeholder analysis, the transition curve

Key Points: 
  • Implementation - execute the action plan, eg stakeholder analysis, the transition curve
    Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff.
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including 'The Planning of International Drug Development', in the Clinical Research Manual, Euromed and the 'Impact of Brexit', RQA Journal 2017.

Freight Forwarder T.NETWORK to Rebrand as Phoenix International Amidst Strategic Expansion, Tech Focus

Retrieved on: 
Tuesday, July 11, 2023

CHICAGO, July 11, 2023 /PRNewswire/ -- T.NETWORK, an international freight forwarder established in 2018, officially announces its rebranding as Phoenix International. The decision comes on the heels of a large-scale expansion of the workforce, an experienced CEO's entry, and a renewed focus on incorporating technology and innovation into its processes.  

Key Points: 
  • CHICAGO, July 11, 2023 /PRNewswire/ -- T.NETWORK, an international freight forwarder established in 2018, officially announces its rebranding as Phoenix International .
  • By integrating a key strategic partner's retail division, Phoenix International more than doubles its team's size, signaling its strong growth ambitions.
  • By establishing a strategic partnership with freight forwarding-focused R&D company SmartBee Intelligence, the company signals its continuing commitment to innovation-driven service improvement.
  • "Phoenix International represents a rebirth of exceptional quality service in freight forwarding, blending superior customer service with advanced technology," says Emil Sanchez, CEO.

2023 CAPA (Corrective and Preventative Action) Procedures Training Course: How to Improve your Processes and Implement and Document an Effective CAPA Quality System - ResearchAndMarkets.com

Retrieved on: 
Friday, July 7, 2023

Implementation - execute the action plan, eg stakeholder analysis, the transition curve

Key Points: 
  • Implementation - execute the action plan, eg stakeholder analysis, the transition curve
    Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff.
  • She has more than 20 years' experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.
  • She regularly writes on pharmaceutical regulatory issues including "The Planning of International Drug Development", in the Clinical Research Manual, Euromed and the "Impact of Brexit", RQA Journal 2017.

The Pharma Mini MBA Training Course: Featuring Business School Pharmaceutical Case Studies

Retrieved on: 
Friday, April 21, 2023

BSc (Economics), MSc (Health Economics) Leela Barham is an independent health economist and policy expert working on a freelance basis.

Key Points: 
  • BSc (Economics), MSc (Health Economics) Leela Barham is an independent health economist and policy expert working on a freelance basis.
  • This follows 7 years at a specialist economic consulting firm working in a small dedicated health and pharmaceutical team.
  • She regularly writes on hot topics affecting the industry for Pharmaceutical Executive, Pharmaphorum and EyeforPharma and has also written for PharmaTimes, and Pharma Pricing and Reimbursement.
  • Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff.

The Pharma Mini MBA Training Course: Accelerated Management Programme for Pharmaceutical Industry Employees - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 19, 2023

BSc (Economics), MSc (Health Economics) Leela Barham is an independent health economist and policy expert working on a freelance basis.

Key Points: 
  • BSc (Economics), MSc (Health Economics) Leela Barham is an independent health economist and policy expert working on a freelance basis.
  • This follows 7 years at a specialist economic consulting firm working in a small dedicated health and pharmaceutical team.
  • She regularly writes on hot topics affecting the industry for Pharmaceutical Executive, Pharmaphorum and EyeforPharma and has also written for PharmaTimes, and Pharma Pricing and Reimbursement.
  • She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry.

ARC Automotive Announces Alex Qin as acting President and CEO

Retrieved on: 
Friday, May 13, 2022

NINGBO, China, May 13, 2022 /PRNewswire/ -- ARC Automotive, Inc., a leading global provider of automotive safety system technology, today announced that Alex Qin has been named as acting President and CEO.  Previous President and CEO Michael E. Goodin has left the company, effective immediately.

Key Points: 
  • NINGBO, China, May 13, 2022 /PRNewswire/ -- ARC Automotive, Inc., a leading global provider of automotive safety system technology, today announced that Alex Qin has been named as acting President and CEO.
  • Alex Qin, most recently served as ARC's Executive Vice President, focused on strategic planning projects and initiatives.
  • We believe the future is bright at ARC and look forward to the company's achievements and accomplishments," said Zhang Yuming ARC Automotive, Inc. Chairman of the Board.
  • ARC Automotive, Inc. is a global engineering and manufacturing leader in automotive safety system technologies.

ECOTEC to Partner with Archrock on Methane Emissions Management

Retrieved on: 
Tuesday, April 26, 2022

Ecotec International Holdings, LLC (ECOTEC) today announced a strategic minority equity investment by Archrock, Inc. (Archrock), Archrock is an energy infrastructure company with a pure-play focus on midstream natural gas compression.

Key Points: 
  • Ecotec International Holdings, LLC (ECOTEC) today announced a strategic minority equity investment by Archrock, Inc. (Archrock), Archrock is an energy infrastructure company with a pure-play focus on midstream natural gas compression.
  • The strategic investment by Archrock accelerates ECOTECs expansion into the oil and gas industry.
  • Tim Novick, President and Chief Executive Officer of ECOTEC, said, We are thrilled to partner with Archrock as an increasing number of oil and gas companies commit to thoughtful ESG strategies to measure and reduce their methane emissions.
  • In particular, methane leak mitigation will be critical in solidifying the important role natural gas will play in energy transition.